Nanoencapsulation and characterisation of Hypericum perforatum for the treatment of neuropathic pain.

AIM: This work aimed to encapsulate Hypericum perforatum extract (HPE) into nanophytosomes (NPs) and assess the therapeutic efficacy of this nanocarrier in neuropathic pain induced by partial sciatic nerve ligation (PSNL). METHODS: Hydroalcoholic extract of Hypericum perforatum was prepared and encapsulated into NPs by thin layer hydration method. Particle size, zeta potential, TEM, differential scanning calorimetry (DSC), entrapment efficiency (%EE), and loading capacity (LC) of NPs were reported. The biochemical and histopathological examinations were measured in the sciatic nerve. RESULTS: Particle size, zeta potential, %EE, and LC were 104.7 ± 1.529 nm, -8.93 ± 1.71 mV, 87.23 ± 1.3%, and 53.12 ± 1.7%, respectively. TEM revealed well-formed and distinct vesicles. NPHPE (NPs of HPE) was significantly more effective than HPE in reducing PSNL-inducing pain. Antioxidant levels and sciatic nerve histology were reversed to normal with NPHPE. CONCLUSIONS: This study demonstrates that encapsulating HPE with phytosomes is an effective therapeutic approach for neuropathic pain.

Assessment of progeny concentrations of 222Rn/220Rn and their related doses using deposition-based direct progeny sensors.

Indoor radon and thoron concentrations in the domestic environment result in natural radiation exposure to the public due to the inhalation of their short-lived decay products. Keeping this in view, the annual effective dose and other radiation risks due to radon/thoron progenies have been calculated. In this study, newly developed time deposition-based progeny sensors (DTPS/DRPS) were used for long-term passive determination of progeny concentrations in the environment of Jammu and Kashmir, Himalayas, India. The total equilibrium equivalent radon (EECRA + U) and thoron (EECTA + U) concentrations ("A" and "U" referring to attached and unattached fractions) were found to vary from 5 to 38 Bq m-3 with an average value of 18 Bq m-3 and from 0.48 to 5.49 Bq m-3 with an average value of 1.69 Bq m-3, respectively. The aerosol concentration, equilibrium factors, and unattached fractions for radon and thoron progeny have been estimated in normal living conditions and their dependence on each others have also been studied. The annual equilibrium factor for radon and thoron progeny has been determined from the calculated data. The estimated annual effective dose due to radon progeny (0.34 to 2.42 mSv y-1) and thoron progeny (0.13 to 1.54 mSv y-1) is found to be below the world's recommended level. Based on measurements of mean values of the unattached fraction, dose conversion factors (DCFs) in units of mSv per working level month (WLM) has been calculated and the average calculated values of DCFs are 24, 10, and 13 mSv WLM-1. The variability of equilibrium factor and radon/thoron progeny with different seasons, ventilation conditions, and types of houses were also analyzed.

STUDY OF RADIATION EXPOSURE DUE TO RADON, THORON AND PROGENY IN THE INDOOR ENVIRONMENT OF YAMUNA AND TONS VALLEYS OF GARHWAL HIMALAYA.

Long-term measurements of indoor radon, thoron and their progeny concentrations have been carried out in dwellings of Yamuna and Tons Valleys of Uttarkashi, Garhwal Himalaya to investigate the health risk associated with inhalation of radon, thoron and progeny. The experimentally determined values of radon, thoron and progeny concentrations were used to estimate the annual inhalation doses and annual effective doses. The annual inhalation dose has been found to vary from 0.8 to 3.9 mSv y-1 with an average of 1.8 mSv y-1 The annual effective dose from the exposure to radon and its progeny in the study area has been found to vary from 0.1 to 2.4 mSv with an average of 1.2±0.6 mSv. Similarly, the annual effective dose due to thoron and its progeny has been found to vary from 0.2 to 1.5 mSv with an average of 0.6±0.4. The measurement techniques and results obtained are discussed in detail.

Inhalation exposures due to radon and thoron ((222)Rn and (220)Rn): Do they differ in high and normal background radiation areas in India?

In India, High Background Radiation Areas (HBRAs) due to enhanced levels of naturally occurring radionuclides in soil (thorium and, to a lesser extent, uranium), are located along some parts of the coastal tracts viz. the coastal belt of Kerala, Tamilnadu and Odisha. It is conjectured that these deposits will result in higher emissions of radon isotopes ((222)Rn and (220)Rn) and their daughter products as compared to Normal Background Radiation Areas (NBRAs). While the annual external dose rates contributed by gamma radiations in these areas are about 5-10 times higher, the extent of increase in the inhalation dose rates attributable to (222)Rn and (220)Rn and their decay products is not well quantified. Towards this, systematic indoor surveys were conducted wherein simultaneous measurements of time integrated (222)Rn and (220)Rn gas and their decay product concentrations was carried out in around 800 houses in the HBRAs of Kerala and Odisha to estimate the inhalation doses. All gas measurements were carried out using pin-hole cup dosimeters while the progeny measurements were with samplers and systems based on the Direct radon/thoron Progeny sensors (DRPS/DTPS). To corroborate these passive measurements of decay products concentrations, active sampling was also carried out in a few houses. The results of the surveys provide a strong evidence to conclude that the inhalation doses due to (222)Rn and (220)Rn gas and their decay products in these HBRAs are in the same range as observed in the NBRAs in India.